AUC,Rank,Term_Name,Overlapping_Genes,Adjusted_P-value,Source
0.5,3,Aldosterone synthesis and secretion,"KCNJ5, SCARB1, KCNK9",0.12538662263575343,KEGG_2019_Human
0.5,1,MAPK signaling pathway,"NTRK2, CACNB2, FGF9, IGF1, MAPK8IP3",0.12643621645344325,KEGG_2019_Human
0.5,2,Vitamin digestion and absorption,"SCARB1, SLC46A1",0.18623016929622316,KEGG_2019_Human
0.5,4,Breast cancer,"FGF9, IGF1, ESR2",0.2981093211330034,KEGG_2019_Human
0.5,5,Ovarian steroidogenesis,"SCARB1, IGF1",0.3067819382741731,KEGG_2019_Human
0.5,6,Melanoma,"FGF9, IGF1",0.5385786474137163,KEGG_2019_Human
0.5,8,Hypertrophic cardiomyopathy (HCM),"CACNB2, IGF1",0.5543402245566791,KEGG_2019_Human
0.5,9,Dilated cardiomyopathy (DCM),"CACNB2, IGF1",0.5606443651378281,KEGG_2019_Human
0.5,7,Ras signaling pathway,"NTRK2, FGF9, IGF1",0.5948089912421464,KEGG_2019_Human
0.5,14,Oxytocin signaling pathway,"KCNJ5, CACNB2",0.941530733505263,KEGG_2019_Human
0.5,17,Aldosterone-regulated sodium reabsorption,IGF1,1.0,KEGG_2019_Human
0.5,18,Fat digestion and absorption,SCARB1,1.0,KEGG_2019_Human
0.5,19,Sphingolipid metabolism,SPTLC2,1.0,KEGG_2019_Human
0.5,10,Estrogen signaling pathway,"KCNJ5, ESR2",1.0,KEGG_2019_Human
0.5,11,Apoptosis,"SPTAN1, TUBA4A",1.0,KEGG_2019_Human
0.5,20,Cholesterol metabolism,SCARB1,1.0,KEGG_2019_Human
0.5,21,Mineral absorption,SLC46A1,1.0,KEGG_2019_Human
0.5,13,Phagosome,"SCARB1, TUBA4A",1.0,KEGG_2019_Human
0.5,23,Pathogenic Escherichia coli infection,TUBA4A,1.0,KEGG_2019_Human
0.5,24,Long-term depression,IGF1,1.0,KEGG_2019_Human
0.55,1,Aldosterone synthesis and secretion,"KCNJ5, LIPE, SCARB1, KCNK9",0.30900068797612523,KEGG_2019_Human
0.55,5,Vitamin digestion and absorption,"SCARB1, SLC46A1",0.31923130936217414,KEGG_2019_Human
0.55,2,MAPK signaling pathway,"NTRK2, CACNB2, FGF9, IGF1, MAPK8IP3, DUSP6",0.3328770615533252,KEGG_2019_Human
0.55,4,Breast cancer,"CDKN1A, FGF9, IGF1, ESR2",0.3380044054290887,KEGG_2019_Human
0.55,3,Melanoma,"CDKN1A, FGF9, IGF1",0.43124128816719165,KEGG_2019_Human
0.55,11,Hepatitis C,"SCARB1, CDKN1A, TLR3",0.9203632787582311,KEGG_2019_Human
0.55,16,Taurine and hypotaurine metabolism,BAAT,0.931945435889827,KEGG_2019_Human
0.55,17,Transcriptional misregulation in cancer,"CDKN1A, IGF1, DUSP6",0.936043978404217,KEGG_2019_Human
0.55,18,Hypertrophic cardiomyopathy (HCM),"CACNB2, IGF1",0.9618442029452203,KEGG_2019_Human
0.55,10,Oxytocin signaling pathway,"KCNJ5, CACNB2, CDKN1A",0.9796616936759529,KEGG_2019_Human
0.55,7,Caffeine metabolism,CYP2A6,0.9812202054339252,KEGG_2019_Human
0.55,14,Glioma,"CDKN1A, IGF1",0.9891576614252041,KEGG_2019_Human
0.55,13,p53 signaling pathway,"CDKN1A, IGF1",0.9896536923583883,KEGG_2019_Human
0.55,15,Synaptic vesicle cycle,"UNC13A, SLC6A9",0.9905205115411593,KEGG_2019_Human
0.55,6,Ovarian steroidogenesis,"SCARB1, IGF1",1.0,KEGG_2019_Human
0.55,21,Primary bile acid biosynthesis,BAAT,1.0,KEGG_2019_Human
0.55,8,Long-term depression,"GRID2, IGF1",1.0,KEGG_2019_Human
0.55,12,Bile secretion,"SCARB1, BAAT",1.0,KEGG_2019_Human
0.55,28,Biosynthesis of unsaturated fatty acids,BAAT,1.0,KEGG_2019_Human
0.55,9,Phagosome,"SCARB1, SFTPA1, TUBA4A",1.0,KEGG_2019_Human
0.6,7,Breast cancer,"CDKN1A, FGF9, IGF1, ESR2",0.2801879756298561,KEGG_2019_Human
0.6,2,Ovarian steroidogenesis,"SCARB1, LHCGR, IGF1",0.2912462036134332,KEGG_2019_Human
0.6,6,Vitamin digestion and absorption,"SCARB1, SLC46A1",0.3264054311858569,KEGG_2019_Human
0.6,4,Aminoacyl-tRNA biosynthesis,"CARS, YARS, GARS",0.34019766062895107,KEGG_2019_Human
0.6,5,Melanoma,"CDKN1A, FGF9, IGF1",0.3471426414286144,KEGG_2019_Human
0.6,3,MAPK signaling pathway,"CACNB2, NTRK2, FGF9, IGF1, MAPK8IP3, DUSP6",0.3761202667130457,KEGG_2019_Human
0.6,1,Aldosterone synthesis and secretion,"SCARB1, LIPE, KCNJ5, KCNK9",0.4568543903703336,KEGG_2019_Human
0.6,8,Caffeine metabolism,CYP2A6,0.9530108556543047,KEGG_2019_Human
0.6,17,Glioma,"CDKN1A, IGF1",0.9831883551304579,KEGG_2019_Human
0.6,18,Synaptic vesicle cycle,"UNC13A, SLC6A9",0.9953218610518265,KEGG_2019_Human
0.6,16,Taurine and hypotaurine metabolism,BAAT,1.0,KEGG_2019_Human
0.6,22,Primary bile acid biosynthesis,BAAT,1.0,KEGG_2019_Human
0.6,9,Long-term depression,"GRID2, IGF1",1.0,KEGG_2019_Human
0.6,13,Prolactin signaling pathway,"LHCGR, ESR2",1.0,KEGG_2019_Human
0.6,14,Bile secretion,"SCARB1, BAAT",1.0,KEGG_2019_Human
0.6,15,p53 signaling pathway,"CDKN1A, IGF1",1.0,KEGG_2019_Human
0.6,30,Biosynthesis of unsaturated fatty acids,BAAT,1.0,KEGG_2019_Human
0.6,20,Hypertrophic cardiomyopathy (HCM),"CACNB2, IGF1",1.0,KEGG_2019_Human
0.6,10,Phagosome,"SCARB1, SFTPA1, TUBA4A",1.0,KEGG_2019_Human
0.6,11,Oxytocin signaling pathway,"CACNB2, KCNJ5, CDKN1A",1.0,KEGG_2019_Human
0.65,8,Melanoma,"CDKN1A, FGF9, IGF1",0.3342100240951879,KEGG_2019_Human
0.65,9,Breast cancer,"CDKN1A, FGF9, IGF1, ESR2",0.3745546105344453,KEGG_2019_Human
0.65,7,Bile secretion,"SCARB1, BAAT, CYP7A1",0.3819543132516433,KEGG_2019_Human
0.65,6,Vitamin digestion and absorption,"SCARB1, SLC46A1",0.44195888073205,KEGG_2019_Human
0.65,3,Primary bile acid biosynthesis,"BAAT, CYP7A1",0.4473250462726302,KEGG_2019_Human
0.65,2,Ovarian steroidogenesis,"SCARB1, LHCGR, IGF1",0.45509124150927266,KEGG_2019_Human
0.65,5,MAPK signaling pathway,"CACNB2, NTRK2, FGF9, IGF1, MAPK8IP3, DUSP6",0.48167254435820517,KEGG_2019_Human
0.65,4,Aminoacyl-tRNA biosynthesis,"CARS, YARS, GARS",0.5259861426701817,KEGG_2019_Human
0.65,1,Aldosterone synthesis and secretion,"SCARB1, LIPE, KCNJ5, KCNK9",0.8108380171932509,KEGG_2019_Human
0.65,10,Caffeine metabolism,CYP2A6,0.8905033419064843,KEGG_2019_Human
0.65,11,Cholesterol metabolism,"SCARB1, CYP7A1",0.9697823091891556,KEGG_2019_Human
0.65,16,Taurine and hypotaurine metabolism,BAAT,1.0,KEGG_2019_Human
0.65,12,Long-term depression,"GRID2, IGF1",1.0,KEGG_2019_Human
0.65,13,Central carbon metabolism in cancer,"SCO2, IDH1",1.0,KEGG_2019_Human
0.65,18,Prolactin signaling pathway,"LHCGR, ESR2",1.0,KEGG_2019_Human
0.65,19,p53 signaling pathway,"CDKN1A, IGF1",1.0,KEGG_2019_Human
0.65,29,Biosynthesis of unsaturated fatty acids,BAAT,1.0,KEGG_2019_Human
0.65,20,Glioma,"CDKN1A, IGF1",1.0,KEGG_2019_Human
0.65,21,Synaptic vesicle cycle,"UNC13A, SLC6A9",1.0,KEGG_2019_Human
0.65,34,Citrate cycle (TCA cycle),IDH1,1.0,KEGG_2019_Human
0.7,5,Primary bile acid biosynthesis,"BAAT, CYP7A1",0.41264254681242185,KEGG_2019_Human
0.7,4,Cholesterol metabolism,"SCARB1, PCSK9, CYP7A1",0.4475662992341714,KEGG_2019_Human
0.7,7,Vitamin digestion and absorption,"SCARB1, SLC46A1",0.5785478632482894,KEGG_2019_Human
0.7,1,Bile secretion,"SCARB1, SLC10A2, BAAT, CYP7A1",0.587756322462971,KEGG_2019_Human
0.7,3,Aldosterone synthesis and secretion,"SCARB1, LIPE, KCNJ5, KCNK9",0.5946938066507177,KEGG_2019_Human
0.7,8,Melanoma,"CDKN1A, FGF9, IGF1",0.6063429602358404,KEGG_2019_Human
0.7,6,Aminoacyl-tRNA biosynthesis,"CARS, YARS, GARS",0.6401905015846667,KEGG_2019_Human
0.7,10,Breast cancer,"CDKN1A, FGF9, IGF1, ESR2",0.7025878279652847,KEGG_2019_Human
0.7,11,Phagosome,"SCARB1, ATP6AP1, SFTPA1, TUBA4A",0.7112675791710683,KEGG_2019_Human
0.7,9,MAPK signaling pathway,"CACNB2, NTRK2, FGF9, IGF1, MAPK8IP3, DUSP6",0.7312221478703483,KEGG_2019_Human
0.7,2,Ovarian steroidogenesis,"SCARB1, LHCGR, IGF1",0.8458921566004819,KEGG_2019_Human
0.7,12,Caffeine metabolism,CYP2A6,0.9233408323623272,KEGG_2019_Human
0.7,15,Taurine and hypotaurine metabolism,BAAT,1.0,KEGG_2019_Human
0.7,14,Long-term depression,"GRID2, IGF1",1.0,KEGG_2019_Human
0.7,16,Central carbon metabolism in cancer,"SCO2, IDH1",1.0,KEGG_2019_Human
0.7,17,Retinol metabolism,"CYP26B1, CYP2A6",1.0,KEGG_2019_Human
0.7,13,AMPK signaling pathway,"LIPE, IGF1, RAB11B",1.0,KEGG_2019_Human
0.7,18,Prolactin signaling pathway,"LHCGR, ESR2",1.0,KEGG_2019_Human
0.7,19,p53 signaling pathway,"CDKN1A, IGF1",1.0,KEGG_2019_Human
0.7,34,Biosynthesis of unsaturated fatty acids,BAAT,1.0,KEGG_2019_Human
0.75,1,Cholesterol metabolism,"SCARB1, PCSK9, APOA1, LCAT, APOE, CYP7A1",0.004267899210428067,KEGG_2019_Human
0.75,2,Vitamin digestion and absorption,"SCARB1, SLC46A1, APOA1",0.3063871215624168,KEGG_2019_Human
0.75,9,Fat digestion and absorption,"SCARB1, APOA1, CEL",0.3145038248954233,KEGG_2019_Human
0.75,8,Neurotrophin signaling pathway,"CAMK2B, NTRK2, MAP3K1, IRAK3, SOS2",0.33212740368391047,KEGG_2019_Human
0.75,7,Glioma,"CAMK2B, CDKN1A, IGF1, SOS2",0.3592407019101674,KEGG_2019_Human
0.75,11,Primary bile acid biosynthesis,"BAAT, CYP7A1",0.38008388802259846,KEGG_2019_Human
0.75,12,Ovarian steroidogenesis,"SCARB1, LHCGR, IGF1",0.38342184030255894,KEGG_2019_Human
0.75,3,Aldosterone synthesis and secretion,"CAMK2B, SCARB1, LIPE, KCNJ5, KCNK9",0.3929935500314836,KEGG_2019_Human
0.75,6,Hepatitis B,"CDKN1A, MAP3K1, ATP6AP1, JAK2, SOS2, TLR3",0.39822081573301055,KEGG_2019_Human
0.75,10,MAPK signaling pathway,"CACNB2, NTRK2, MAP3K1, FGF9, IGF1, MAPK8IP3, SOS2, DUSP6",0.4099415663215929,KEGG_2019_Human
0.75,5,Bile secretion,"SCARB1, SLC10A2, BAAT, CYP7A1",0.4362041122544359,KEGG_2019_Human
0.75,13,Breast cancer,"CDKN1A, FGF9, IGF1, SOS2, ESR2",0.47288014450259347,KEGG_2019_Human
0.75,4,Prolactin signaling pathway,"LHCGR, JAK2, SOS2, ESR2",0.49392016605637595,KEGG_2019_Human
0.75,14,Phagosome,"C3, SCARB1, ATP6AP1, SFTPA1, TUBA4A",0.49902251304367023,KEGG_2019_Human
0.75,15,Hepatitis C,"SCARB1, CDKN1A, CLDN14, SOS2, TLR3",0.5015712932096027,KEGG_2019_Human
0.75,18,Tight junction,"MAP3K1, CLDN14, ACTN1, MYH8, TUBA4A",0.5891933757178575,KEGG_2019_Human
0.75,17,Aminoacyl-tRNA biosynthesis,"CARS, YARS, GARS",0.5906003553678245,KEGG_2019_Human
0.75,16,Cholinergic synapse,"CHRNB2, CAMK2B, KCNQ5, JAK2",0.5959189893746784,KEGG_2019_Human
0.75,21,Tuberculosis,"C3, CAMK2B, ATP6AP1, JAK2, MALT1",0.6086366261845393,KEGG_2019_Human
0.75,20,p53 signaling pathway,"CDKN1A, IGF1, PPM1D",0.6252457128520813,KEGG_2019_Human
0.8,1,Cholesterol metabolism,"SCARB1, LRPAP1, LIPG, PCSK9, APOA1, LCAT, APOE, CYP7A1",0.00029287551673406076,KEGG_2019_Human
0.8,2,Aldosterone synthesis and secretion,"CAMK2B, SCARB1, LIPE, KCNJ5, KCNK9, GNA11, AGTR1, CACNA1C, CALM1",0.0034144927785732444,KEGG_2019_Human
0.8,10,Amphetamine addiction,"CAMK2B, CACNA1C, PDYN, CALM1, GRIA4",0.1270731993939796,KEGG_2019_Human
0.8,11,Prolactin signaling pathway,"LHCGR, JAK2, SOS2, ESR2, INS",0.1308046971604528,KEGG_2019_Human
0.8,9,Pathways in cancer,"CAMK2B, CDKN1A, FZD2, TERC, IGF1, ESR2, EPOR, FGF8, RAD51, FGF9, MSH3, GNA11, COL4A3, AGTR1, CALM1, JAK2, SOS2",0.1392421401606558,KEGG_2019_Human
0.8,5,MAPK signaling pathway,"CACNB2, NTRK2, MAP3K1, FGF8, FGF9, IGF1, CACNA1C, MAPK8IP3, SOS2, DUSP6, EPHA2, INS",0.1451699531272012,KEGG_2019_Human
0.8,7,GnRH signaling pathway,"CAMK2B, MAP3K1, GNA11, CACNA1C, CALM1, SOS2",0.14566595400620883,KEGG_2019_Human
0.8,13,Glioma,"CAMK2B, CDKN1A, IGF1, CALM1, SOS2",0.1482566743503941,KEGG_2019_Human
0.8,12,Vitamin digestion and absorption,"SCARB1, SLC46A1, APOA1",0.15186749670632424,KEGG_2019_Human
0.8,4,Adrenergic signaling in cardiomyocytes,"CAMK2B, CACNB2, PLN, AGTR1, PPP2R5D, CACNA1C, CALM1, MYH6",0.1522763555834144,KEGG_2019_Human
0.8,6,Cushing syndrome,"CAMK2B, SCARB1, CDKN1A, PDE11A, FZD2, GNA11, AGTR1, CACNA1C",0.15355766358918765,KEGG_2019_Human
0.8,14,Ovarian steroidogenesis,"SCARB1, LHCGR, IGF1, INS",0.15426873224720516,KEGG_2019_Human
0.8,8,Hepatitis B,"IFIH1, CDKN1A, DDX3X, MAP3K1, ATP6AP1, JAK2, SOS2, TLR3",0.15637895852014397,KEGG_2019_Human
0.8,18,PI3K-Akt signaling pathway,"NTRK2, CDKN1A, FGF8, FGF9, COL4A3, PPP2R5D, IGF1, JAK2, SOS2, EPOR, EPHA2, INS",0.1674278309724366,KEGG_2019_Human
0.8,15,Breast cancer,"CDKN1A, FGF8, FZD2, FGF9, IGF1, SOS2, ESR2",0.1691037356903879,KEGG_2019_Human
0.8,20,Insulin secretion,"CAMK2B, GNA11, CACNA1C, INS, TRPM4",0.16950816788156264,KEGG_2019_Human
0.8,17,Thyroid hormone signaling pathway,"HDAC3, PLN, THRA, SIN3A, MYH6, PLCD1",0.17390479921824434,KEGG_2019_Human
0.8,19,Neurotrophin signaling pathway,"CAMK2B, NTRK2, MAP3K1, IRAK3, CALM1, SOS2",0.17513968576187203,KEGG_2019_Human
0.8,16,Calcium signaling pathway,"CAMK2B, LHCGR, PLN, GNA11, AGTR1, CACNA1C, CALM1, PLCD1",0.18027990670488436,KEGG_2019_Human
0.8,3,Cholinergic synapse,"CHRNB2, CAMK2B, CHRNA4, GNA11, KCNQ5, CACNA1C, JAK2",0.19001266626674176,KEGG_2019_Human
0.85,1,Cholesterol metabolism,"ABCA1, SCARB1, LRPAP1, LIPG, PCSK9, APOA1, LCAT, APOE, LDLRAP1, LPA, CYP7A1",5.1757825513772655e-06,KEGG_2019_Human
0.85,2,Aldosterone synthesis and secretion,"CAMK2B, SCARB1, KCNJ5, KCNK9, CAMK2A, ATP2B2, CACNA1C, CACNA1H, CACNA1G, LIPE, CYP11B2, GNA11, AGTR1, CALM1",1.015960644261421e-05,KEGG_2019_Human
0.85,3,Amphetamine addiction,"PPP1CB, CAMK2B, CAMK2A, CACNA1C, PDYN, CALM1, GRIA3, GRIA4",0.01877951880974858,KEGG_2019_Human
0.85,10,MAPK signaling pathway,"NTRK2, MAP3K1, HSPB1, IGF1, CACNA1C, MAPK8IP3, DUSP6, CACNA1H, CACNA1G, INS, CDC42, CACNB2, FGF8, FGF9, RAC1, SOS2, EPHA2",0.019259801340744197,KEGG_2019_Human
0.85,5,Pathways in cancer,"CAMK2B, CDKN1A, TERC, LAMC3, CAMK2A, GLI2, LRP6, DLL4, CDC42, FGF8, FGF9, GNA11, RAC1, JAK2, SMAD2, FZD2, IGF1, ESR2, EPOR, RAD51, COL4A2, MSH3, COL4A3, AGTR1, CALM1, SOS2",0.0209148641923551,KEGG_2019_Human
0.85,9,Adrenergic signaling in cardiomyocytes,"PPP1CB, CAMK2B, CACNB2, PLN, CAMK2A, AGTR1, PPP2R5D, ATP2B2, CACNA1C, CALM1, MYH6",0.021297161327673567,KEGG_2019_Human
0.85,7,Neurotrophin signaling pathway,"CAMK2B, CDC42, NTRK2, MAP3K1, CAMK2A, IRAK3, PSEN1, RAC1, CALM1, SOS2",0.021548185517336484,KEGG_2019_Human
0.85,8,AGE-RAGE signaling pathway in diabetic complications,"SMAD2, CDC42, DIAPH1, COL4A2, COL4A3, AGTR1, RAC1, JAK2, PLCD1",0.021714936091953657,KEGG_2019_Human
0.85,11,Cortisol synthesis and secretion,"SCARB1, GNA11, AGTR1, NR0B1, CACNA1C, CACNA1H, CACNA1G",0.022201780184400863,KEGG_2019_Human
0.85,4,Cushing syndrome,"CAMK2B, SCARB1, CDKN1A, PDE11A, FZD2, GNA11, CAMK2A, AIP, AGTR1, CACNA1C, CACNA1H, CACNA1G",0.022829793256547454,KEGG_2019_Human
0.85,6,Circadian entrainment,"CAMK2B, KCNJ5, CAMK2A, CACNA1C, CALM1, CACNA1H, GRIA3, CACNA1G, GRIA4",0.023132257611789733,KEGG_2019_Human
0.85,14,Calcium signaling pathway,"CAMK2B, LHCGR, PLN, GNA11, CAMK2A, AGTR1, ATP2B2, CACNA1C, CALM1, CACNA1H, PLCD1, CACNA1G",0.03589633374168021,KEGG_2019_Human
0.85,13,cAMP signaling pathway,"CAMK2B, PDE4D, CAMK2A, ATP2B2, CACNA1C, TSHR, PPP1CB, LIPE, PLN, RAC1, CALM1, GRIA3, GRIA4",0.036126005760497515,KEGG_2019_Human
0.85,12,GnRH signaling pathway,"CAMK2B, CDC42, MAP3K1, GNA11, CAMK2A, CACNA1C, CALM1, SOS2",0.038953809962723185,KEGG_2019_Human
0.85,17,Maturity onset diabetes of the young,"NEUROD1, PAX6, MAFA, INS",0.053281038858706165,KEGG_2019_Human
0.85,15,Focal adhesion,"PPP1CB, CDC42, DIAPH1, COL4A2, VWF, LAMC3, ACTN1, COL4A3, IGF1, RAC1, SOS2, ACTG1",0.053803697567470006,KEGG_2019_Human
0.85,16,Proteoglycans in cancer,"PPP1CB, SMAD2, CAMK2B, CDC42, CDKN1A, FZD2, CAMK2A, ANK2, IGF1, RAC1, SOS2, ACTG1",0.05474433824759108,KEGG_2019_Human
0.85,18,Dopaminergic synapse,"PPP1CB, CAMK2B, KCNJ5, CAMK2A, PPP2R5D, CACNA1C, CALM1, GRIA3, GRIA4",0.0637108820540533,KEGG_2019_Human
0.85,20,PI3K-Akt signaling pathway,"NTRK2, CDKN1A, VWF, LAMC3, PPP2R5D, IGF1, EPOR, INS, FGF8, FGF9, COL4A2, COL4A3, RAC1, JAK2, SOS2, YWHAG, EPHA2",0.06625546283223338,KEGG_2019_Human
0.85,19,Wnt signaling pathway,"CAMK2B, PORCN, FZD2, TBL1XR1, CHD8, CSNK2B, CAMK2A, PSEN1, RAC1, LRP6",0.06681954323499997,KEGG_2019_Human
0.9,1,Cholesterol metabolism,"ABCA1, SCARB1, ABCG8, LRPAP1, ABCG5, PCSK9, APOA1, LCAT, LRP2, CYP7A1, CYP27A1, NPC2, LIPG, ANGPTL3, APOE, LDLRAP1, LPA",6.660437124319301e-10,KEGG_2019_Human
0.9,2,Dilated cardiomyopathy (DCM),"RYR2, ITGB4, TPM3, TPM2, TNNC1, ATP2A2, CACNA1C, IGF1, CACNA1F, ACTB, ACTG1, CACNB2, PLN, ACTC1, SGCB, MYL2, CACNA1S, EMD, MYH6",2.1045595902820188e-07,KEGG_2019_Human
0.9,3,Hypertrophic cardiomyopathy (HCM),"RYR2, ITGB4, TPM3, TPM2, TNNC1, ATP2A2, CACNA1C, IGF1, CACNA1F, ACTB, ACTG1, CACNB2, ACTC1, SGCB, MYL2, CACNA1S, EMD, MYH6",2.9901698804763085e-07,KEGG_2019_Human
0.9,4,Cushing syndrome,"CAMK2B, SCARB1, KMT2D, MAP2K1, CDKN1A, FZD2, CDKN1B, KMT2A, FZD4, CDKN2A, CAMK2A, AIP, CACNA1C, CACNA1F, CACNA1H, CACNA1G, PDE11A, ARMC5, CYP21A2, GNA11, DVL1, AGTR1, CTNNB1, CACNA1S",4.46167144333583e-07,KEGG_2019_Human
0.9,5,Adrenergic signaling in cardiomyocytes,"CAMK2B, RYR2, TPM3, TPM2, TNNC1, CAMK2A, ATP2A2, PPP2R5D, ATP2B2, CACNA1C, CACNA1F, PPP1CB, CACNB2, PLN, ACTC1, PPP2R1A, MYL2, AKT3, AGTR1, CACNA1S, CALM1, SCN1B, MYH6",4.6078520730198516e-07,KEGG_2019_Human
0.9,6,Focal adhesion,"LAMC3, ITGB4, PDGFB, ACTB, ACTG1, PPP1CB, CDC42, AKT3, RAC1, MAP2K1, CAV3, VWF, ACTN1, CAV1, IGF1, COL1A1, DIAPH1, COL4A2, MYL2, COL4A3, CTNNB1, COL4A5, COL9A3, COL9A2, SOS2, VCL",2.587907296377006e-06,KEGG_2019_Human
0.9,7,Pathways in cancer,"CAMK2B, CDKN1A, CDKN1B, TERC, LAMC3, CAMK2A, PDGFB, CXCR4, GLI2, LRP6, CDC42, DLL4, FGF8, FGF9, GNA11, AKT3, DVL1, EP300, RAC1, POLK, JAK2, IL12RB1, JAK3, SMAD2, MAP2K1, FZD2, SMAD3, FZD4, CDKN2A, TPM3, PLEKHG5, IGF1, MTOR, ESR2, EPOR, AR, RAD51, COL4A2, MSH3, COL4A3, GNB1, AGTR1, CTNNB1, FAS, COL4A5, CALM1, SOS2",4.109212394944386e-06,KEGG_2019_Human
0.9,8,Aldosterone synthesis and secretion,"CAMK2B, SCARB1, KCNJ5, KCNK9, CAMK2A, ATP2B2, CACNA1C, CACNA1F, CACNA1H, CACNA1G, LIPE, CYP11B2, CYP21A2, GNA11, AGTR1, CACNA1S, CALM1",6.876938236185287e-06,KEGG_2019_Human
0.9,9,Human papillomavirus infection,"CDKN1A, CDKN1B, LAMC3, ITGB4, PSEN1, RBPJ, CDC42, TBK1, PPP2R1A, AKT3, DVL1, EP300, BCAP31, MAP2K1, FZD2, ATP6AP1, VWF, FZD4, PPP2R5D, MTOR, COL1A1, COL4A2, DLG3, COL4A3, ATP6V1B2, CTNNB1, FAS, COL4A5, COL9A3, COL9A2, SOS2, TLR3",5.534666416936605e-05,KEGG_2019_Human
0.9,10,Lysine degradation,"KMT2E, GCDH, KMT2D, TMLHE, KMT2A, EHHADH, KMT2C, SETD1A, PLOD2, KMT5B, ASH1L, EZH2",6.182874356618526e-05,KEGG_2019_Human
0.9,11,cAMP signaling pathway,"CAMK2B, RYR2, MAP2K1, EDN3, BDNF, PDE4D, CAMK2A, ATP2A2, ATP2B2, CACNA1C, CACNA1F, TSHR, PPP1CB, LIPE, PLN, AKT3, CNGA1, EP300, SOX9, RAC1, CACNA1S, CALM1, GRIA3, GRIA4",6.386170023368132e-05,KEGG_2019_Human
0.9,12,Arrhythmogenic right ventricular cardiomyopathy (ARVC),"RYR2, ITGB4, ATP2A2, CACNA1C, CACNA1F, ACTB, ACTG1, CACNB2, GJA1, SGCB, CTNNB1, CACNA1S, EMD",7.99824817642525e-05,KEGG_2019_Human
0.9,13,Signaling pathways regulating pluripotency of stem cells,"SMAD2, MAP2K1, SMAD3, FZD2, FZD4, ESRRB, SMAD9, PAX6, HNF1A, IGF1, SOX2, REST, KAT6A, AKT3, DVL1, CTNNB1, JAK2, JAK3",0.0001523533361538147,KEGG_2019_Human
0.9,14,Hepatocellular carcinoma,"SMAD2, MAP2K1, CDKN1A, SMARCC2, SMAD3, FZD2, TERC, FZD4, CDKN2A, ARID1A, ACTB, MTOR, ACTG1, LRP6, AKT3, DVL1, CTNNB1, POLK, ARID2, SOS2",0.00016181542980259122,KEGG_2019_Human
0.9,16,PI3K-Akt signaling pathway,"CDKN1A, CDKN1B, LAMC3, ITGB4, PDGFB, INS, FGF8, FGF9, PPP2R1A, AKT3, RAC1, JAK2, JAK3, YWHAG, NTRK2, MAP2K1, VWF, BDNF, PPP2R5D, IGF1, MTOR, EPOR, COL1A1, COL4A2, COL4A3, GNB1, COL4A5, COL9A3, COL9A2, SOS2, EPHA2",0.0003557278391607999,KEGG_2019_Human
0.9,15,Adherens junction,"CDC42, SMAD2, SMAD3, ACTN1, CSNK2B, EP300, CTNNB1, RAC1, MAP3K7, ACTB, VCL, ACTG1",0.0003581623430558336,KEGG_2019_Human
0.9,19,MAPK signaling pathway,"PDGFB, HSPB1, CACNA1C, CACNA1F, CACNA1H, CACNA1G, INS, CDC42, PPP3CA, FGF8, FGF9, AKT3, RAC1, CACNA1S, MAP3K7, NTRK2, MAP2K1, MAP3K1, BDNF, IGF1, MAPK8IP3, DUSP6, CACNB2, RASA1, FAS, SOS2, EPHA2",0.00047446318867977254,KEGG_2019_Human
0.9,18,AGE-RAGE signaling pathway in diabetic complications,"SMAD2, SMAD3, CDKN1B, COL1A1, CDC42, DIAPH1, COL4A2, AKT3, COL4A3, AGTR1, COL4A5, RAC1, JAK2, PLCD1",0.0004770275802691708,KEGG_2019_Human
0.9,17,Glioma,"CAMK2B, CDKN1A, MAP2K1, CDKN2A, AKT3, CAMK2A, PDGFB, POLK, IGF1, CALM1, SOS2, MTOR",0.00048368183380695433,KEGG_2019_Human
0.9,20,Proteoglycans in cancer,"SMAD2, CAMK2B, CDKN1A, MAP2K1, FZD2, CAV3, FZD4, CAV1, CAMK2A, ANK2, IGF1, ACTB, MTOR, ACTG1, PPP1CB, CDC42, AKT3, CTNNB1, FAS, RAC1, SOS2",0.0005046536592899859,KEGG_2019_Human
0.95,1,Pathways in cancer,"RB1, FGF8, CCND2, FGF9, CDH1, AKT3, EP300, PRKCG, MAP2K1, MAP2K2, TPM3, MITF, MSH6, AR, COL4A2, MSH3, COL4A1, COL4A3, AGTR1, COL4A5, RAF1, TP53, NOTCH2, CSF1R, NOTCH3, TERC, PDGFB, PIK3R2, RASGRP2, DVL1, ABL1, SMAD2, WNT10B, CREBBP, WNT10A, TGFB2, FZD2, JAG1, SMAD3, FZD4, FN1, BRAF, IGF1, ESR2, NFKB2, BMP4, BMP2, GNB1, CALM3, CALM1, CALM2, FGFR1, CDKN1A, CDKN1B, LAMC3, PTEN, SLC2A1, BRCA2, GLI2, MECOM, RAC1, POLK, JAK2, JAK3, HRAS, JAK1, PLEKHG5, PLCB4, PIK3CA, PPARG, SOS1, SOS2, CAMK2B, CEBPA, FH, LAMA3, CAMK2A, CXCR4, CBL, ADCY5, LRP6, CDC42, DLL4, NRAS, GNA11, ERBB2, MAPK1, IL12RB1, NTRK1, STAT1, CDKN2A, VEGFC, MLH1, MTOR, EPOR, KITLG, RAD51, APC, CTNNB1, FAS, KRAS",2.7241737381012182e-17,KEGG_2019_Human
0.95,2,Cholesterol metabolism,"SCARB1, CETP, LRPAP1, PCSK9, LCAT, LPL, LRP2, ABCB11, CYP7A1, LIPC, LIPG, APOE, LDLRAP1, APOB, LDLR, ABCA1, ABCG8, ABCG5, APOA1, CYP27A1, NPC1, NPC2, APOC2, ANGPTL3, LPA",7.578865954933588e-14,KEGG_2019_Human
0.95,3,Human papillomavirus infection,"RB1, CDKN1A, CDKN1B, LAMC3, ITGB4, PTEN, UBE3A, CHD4, RBPJ, COMP, TBK1, CCND2, PPP2R1A, AKT3, EP300, ITGB6, HRAS, JAK1, MAP2K1, MAP2K2, ATP6AP1, VWF, TSC2, PPP2R5D, TUBG1, TNFRSF1A, COL2A1, COL4A2, PIK3CA, COL4A1, COL4A3, ATP6V1B2, COL4A5, RAF1, SOS1, TP53, SOS2, TLR3, ATP6V1B1, NOTCH2, NOTCH3, LAMA3, PIK3R2, PSEN1, CDC42, NRAS, DVL1, ATP6V0A2, MAPK1, BCAP31, WNT10B, CREBBP, WNT10A, FZD2, JAG1, FZD4, STAT1, FN1, MTOR, COL1A1, DLG3, APC, CTNNB1, FAS, COL9A3, KRAS, COL9A2",6.73787501745264e-13,KEGG_2019_Human
0.95,4,Focal adhesion,"LAMC3, ITGB4, PTEN, ACTB, MYLK, ACTG1, PPP1CB, COMP, CCND2, AKT3, RAC1, ITGB6, HRAS, PRKCG, MAP2K1, VWF, ACTN1, COL2A1, COL4A2, PIK3CA, COL4A1, MYL2, COL4A3, COL4A5, RAF1, SOS1, SOS2, VCL, LAMA3, PDGFB, PIK3R2, CDC42, ERBB2, FLNA, MAPK1, FLNB, FLNC, PAK3, CAV3, CAV1, FN1, VEGFC, BRAF, IGF1, COL1A1, DIAPH1, CTNNB1, COL9A3, COL9A2",1.0308086041087999e-12,KEGG_2019_Human
0.95,7,Breast cancer,"RB1, NOTCH2, NOTCH3, CDKN1A, PTEN, PIK3R2, BRCA1, BRCA2, LRP6, DLL4, NRAS, FGF8, FGF9, AKT3, DVL1, ERBB2, MAPK1, POLK, HRAS, WNT10B, MAP2K1, WNT10A, MAP2K2, FZD2, JAG1, FZD4, BRAF, IGF1, ESR2, MTOR, NFKB2, PIK3CA, APC, CTNNB1, KRAS, RAF1, SOS1, TP53, SOS2, FGFR1",4.668674085658446e-12,KEGG_2019_Human
0.95,6,Glioma,"RB1, CAMK2B, CDKN1A, CAMK2A, PTEN, PDGFB, PIK3R2, NRAS, AKT3, MAPK1, POLK, HRAS, PRKCG, MAP2K1, MAP2K2, CDKN2A, BRAF, IGF1, MTOR, PIK3CA, CALM3, KRAS, RAF1, SOS1, CALM1, SOS2, TP53, CALM2",4.706135989414312e-12,KEGG_2019_Human
0.95,8,Thyroid hormone signaling pathway,"NOTCH2, NOTCH3, HDAC3, THRA, SLC2A1, ATP2A2, ATP1A3, PIK3R2, ACTB, ACTG1, MED12, NRAS, PLN, SIN3A, AKT3, EP300, MAPK1, SLC16A2, HRAS, PRKCG, MAP2K1, CREBBP, MAP2K2, STAT1, TSC2, MTOR, BMP4, PLCB4, PIK3CA, CTNNB1, KRAS, RAF1, TP53, MYH6, PLCD1",4.947120450330546e-12,KEGG_2019_Human
0.95,5,Proteoglycans in cancer,"CAMK2B, CDKN1A, CAMK2A, ITPR1, TWIST1, PIK3R2, CBL, ACTB, ACTG1, PPP1CB, CDC42, NRAS, AKT3, ERBB2, TIMP3, FLNA, MAPK1, FLNB, RAC1, FLNC, HRAS, PRKCG, SMAD2, WNT10B, WNT10A, MAP2K1, TGFB2, FZD2, MAP2K2, CAV3, FZD4, CAV1, FN1, ANK2, BRAF, PTPN11, IGF1, HSPG2, MTOR, PIK3CA, CTNNB1, FAS, KRAS, RAF1, SOS1, TP53, SOS2, FGFR1",5.347512266118224e-12,KEGG_2019_Human
0.95,11,Hepatocellular carcinoma,"RB1, CDKN1A, SMARCB1, TERC, PTEN, PIK3R2, ACTB, ACTG1, LRP6, NRAS, AKT3, DVL1, MAPK1, POLK, ARID2, HRAS, PRKCG, SMAD2, SMARCE1, WNT10B, MAP2K1, TGFB2, WNT10A, MAP2K2, SMARCC2, SMAD3, FZD2, FZD4, CDKN2A, BRAF, ARID1A, SMARCA2, ARID1B, MTOR, PIK3CA, APC, CTNNB1, KRAS, RAF1, SOS1, TP53, SOS2",1.6681901725067844e-11,KEGG_2019_Human
0.95,10,Dilated cardiomyopathy (DCM),"RYR2, ITGB4, ATP2A2, CACNA1C, CACNA1F, ACTB, ACTG1, ADCY5, TTN, PLN, SGCA, SGCB, LMNA, DMD, ITGB6, CACNA1S, EMD, MYBPC3, TGFB2, TPM3, TPM2, TNNC1, TPM1, IGF1, CACNB2, DES, ACTC1, MYL2, TNNT2, MYH6",1.6687373510704882e-11,KEGG_2019_Human
0.95,9,Hypertrophic cardiomyopathy (HCM),"RYR2, ITGB4, ATP2A2, CACNA1C, CACNA1F, ACTB, ACTG1, TTN, SGCA, SGCB, LMNA, DMD, ITGB6, CACNA1S, EMD, MYBPC3, TGFB2, ACE, TPM3, TPM2, TNNC1, TPM1, IGF1, CACNB2, DES, ACTC1, MYL2, TNNT2, MYH6",1.670419142713655e-11,KEGG_2019_Human
0.95,12,Signaling pathways regulating pluripotency of stem cells,"PIK3R2, SOX2, NRAS, ZIC3, AKT3, DVL1, HESX1, MAPK1, JAK2, HRAS, JAK3, JAK1, ACVR1, SMAD2, WNT10B, MAP2K1, WNT10A, ZFHX3, MAP2K2, SMAD3, FZD2, FZD4, ESRRB, SMAD9, PAX6, HNF1A, IGF1, BMP4, REST, PIK3CA, APC, KAT6A, CTNNB1, KRAS, RAF1, FGFR1, BMPR1A",4.723211126658117e-11,KEGG_2019_Human
0.95,13,Prostate cancer,"RB1, CDKN1A, CDKN1B, PDGFB, PTEN, PIK3R2, INS, NRAS, AKT3, ERBB2, EP300, MAPK1, HRAS, MAP2K1, CREBBP, MAP2K2, SRD5A2, BRAF, IGF1, MTOR, AR, ZEB1, PIK3CA, CTNNB1, KRAS, RAF1, SOS1, TP53, SOS2, FGFR1",8.319928378164944e-11,KEGG_2019_Human
0.95,14,Renal cell carcinoma,"CDKN1A, FH, SLC2A1, PDGFB, PIK3R2, CDC42, FLCN, NRAS, AKT3, EP300, MAPK1, RAC1, PAK3, HRAS, MAP2K1, TGFB2, CREBBP, MAP2K2, PTPN11, BRAF, PIK3CA, KRAS, RAF1, SOS1, SOS2",9.328636284442931e-11,KEGG_2019_Human
0.95,15,Neurotrophin signaling pathway,"CAMK2B, CAMK2A, PSEN2, PIK3R2, PSEN1, CDC42, RPS6KA3, NRAS, AKT3, ABL1, MAPK1, RAC1, HRAS, NTRK1, NTRK2, MAP2K1, MAP2K2, MAP3K1, BDNF, KIDINS220, BRAF, IRAK3, PTPN11, IRAK4, PIK3CA, CALM3, KRAS, RAF1, CALM1, SOS1, TP53, CALM2, SOS2",1.7513620672829476e-10,KEGG_2019_Human
0.95,16,Cushing syndrome,"RB1, CAMK2B, SCARB1, KMT2D, CDKN1A, FH, CDKN1B, KMT2A, CAMK2A, ITPR1, CACNA1C, CACNA1F, CACNA1H, CACNA1G, ADCY5, PDE11A, GNA11, DVL1, MAPK1, CACNA1S, LDLR, MEN1, WNT10B, MAP2K1, WNT10A, MAP2K2, FZD2, FZD4, CDKN2A, AIP, BRAF, PLCB4, ARMC5, APC, CYP21A2, CYP11B1, AGTR1, CTNNB1",2.7286302684336244e-10,KEGG_2019_Human
0.95,17,Lysosome,"HEXB, CLTC, GBA, LITAF, SGSH, MFSD8, GNPTAB, NAGLU, CTSK, SMPD1, LAMP2, NEU1, ATP6V0A2, SLC17A5, IDS, CTSF, AGA, GUSB, ARSB, CTSA, MANBA, ATP6AP1, FUCA1, GAA, NAGA, AP3B1, AP4B1, GALNS, GALC, NPC1, NPC2, MAN2B1, GLA",4.1379572996091723e-10,KEGG_2019_Human
0.95,18,Endometrial cancer,"CDKN1A, MAP2K1, MAP2K2, PTEN, PIK3R2, BRAF, MLH1, NRAS, PIK3CA, APC, CDH1, AKT3, ERBB2, MAPK1, CTNNB1, KRAS, POLK, RAF1, SOS1, HRAS, SOS2, TP53",4.875192056508883e-10,KEGG_2019_Human
0.95,19,Chronic myeloid leukemia,"RB1, CDKN1A, CDKN1B, PIK3R2, CBL, NRAS, MECOM, AKT3, ABL1, MAPK1, POLK, HRAS, MAP2K1, TGFB2, MAP2K2, SMAD3, CDKN2A, PTPN11, BRAF, PIK3CA, KRAS, RAF1, SOS1, SOS2, TP53",7.933342694032963e-10,KEGG_2019_Human
0.95,20,Central carbon metabolism in cancer,"NTRK1, G6PD, MAP2K1, MAP2K2, PDHA1, IDH1, PGAM2, SLC2A1, PTEN, PIK3R2, GCK, MTOR, NRAS, PIK3CA, SCO2, AKT3, ERBB2, MAPK1, KRAS, RAF1, HRAS, TP53, FGFR1",8.230360054469552e-10,KEGG_2019_Human
1.0,1,Pathways in cancer,"RB1, CSF3R, IGF1R, FGF8, EDNRB, CCND2, FGF9, CDH1, AKT3, AKT1, EP300, PRKCG, PDGFRB, MAP2K1, MAP2K2, TPM3, WNT5A, MITF, RUNX1, MSH6, AR, MSH2, COL4A2, MSH3, COL4A1, COL4A4, COL4A3, AGTR1, COL4A5, RAF1, TP53, NOTCH2, CSF1R, NOTCH3, NOTCH1, TERC, MAX, PDGFB, PIK3R2, RASGRP2, TERT, DVL1, PLCG2, ABL1, DVL3, SMAD2, WNT10B, STAT5B, CREBBP, WNT10A, TGFB2, SMAD4, FZD2, JAG1, SMAD3, JUP, FZD4, TGFB3, PTCH1, PTCH2, FN1, IGF2, BRAF, IGF1, NFKB1, ESR2, NFKB2, NFKBIA, BMP4, BMP2, CDK4, GNB1, GNAS, CALM3, CALM1, CALM2, FGFR3, FGFR2, FGFR1, RET, CDKN1A, CDKN1B, FLT3, LAMC3, FLT4, PTEN, SLC2A1, PIK3CD, LAMC2, BRCA2, GLI3, GLI2, IKBKB, SHH, CASP8, MECOM, SUFU, RAC1, POLK, JAK2, JAK3, HRAS, JAK1, DCC, PLEKHG5, AXIN2, KIF7, TGFBR1, TGFBR2, PLCB4, PAX8, PIK3CA, KIT, PPARG, PLCB1, SOS1, SOS2, MET, CAMK2B, CEBPA, FH, LAMA2, LAMA1, LAMA4, LAMA3, CAMK2A, LRP5, GNAI3, CXCR4, CBL, EGFR, ADCY5, LRP6, DLL3, CDC42, DLL4, NRAS, GNA11, ERBB2, CTNNA1, MAPK1, VHL, IL12RB1, NTRK1, LAMB3, STAT1, CDKN2A, LAMB2, STAT3, VEGFC, LAMB1, MLH1, MTOR, EPOR, KITLG, RAD51, APC, CTNNB1, FAS, KRAS",3.0946165275203496e-30,KEGG_2019_Human
1.0,2,Human papillomavirus infection,"RB1, TNC, UBE3A, RBPJ, COMP, TBK1, CCND2, PPP2R1A, AKT3, AKT1, EP300, PDGFRB, MAP2K1, MAP2K2, WNT5A, TSC2, TSC1, COL4A2, COL4A1, COL4A4, COL4A3, COL4A5, RAF1, TP53, NOTCH2, NOTCH3, NOTCH1, PIK3R2, PSEN1, TERT, DVL1, ATP6V0A2, DVL3, ATP6V0A4, WNT10B, CREBBP, WNT10A, FZD2, JAG1, FZD4, FN1, NFKB1, COL1A1, COL1A2, DLG3, CDK4, COL9A1, GNAS, COL9A3, ATM, COL9A2, ATR, CDKN1A, CDKN1B, LAMC3, ITGB4, PTEN, PIK3CD, LAMC2, CHD4, TCIRG1, IKBKB, CASP8, ITGB6, HRAS, JAK1, ATP6AP1, VWF, PPP2R5D, TYK2, AXIN2, TUBG1, TNFRSF1A, COL2A1, PIK3CA, COL6A2, COL6A1, ATP6V1B2, COL6A3, ITGA7, SOS1, SOS2, TLR3, ATP6V1B1, TNXB, LAMA2, LAMA1, LAMA4, LAMA3, EGFR, CDC42, NRAS, RELN, MAPK1, BCAP31, LAMB3, STAT1, LAMB2, LAMB1, MTOR, APC, CTNNB1, FAS, KRAS",5.0557047827658746e-21,KEGG_2019_Human
1.0,3,Focal adhesion,"LAMC3, ITGB4, FLT4, TNC, PTEN, PIK3CD, LAMC2, ACTB, MYLK, ACTG1, IGF1R, PPP1CB, COMP, CCND2, AKT3, AKT1, RAC1, ITGB6, HRAS, PRKCG, PDGFRB, MAP2K1, VWF, ACTN1, ACTN4, COL2A1, COL4A2, PIK3CA, COL4A1, MYL2, COL4A4, COL6A2, COL4A3, COL6A1, COL4A5, COL6A3, ITGA7, RAF1, SOS1, SOS2, MET, VCL, TNXB, LAMA2, LAMA1, LAMA4, LAMA3, PDGFB, PIK3R2, EGFR, CDC42, RELN, ERBB2, FLNA, MAPK1, FLNB, FLNC, PAK3, CAV3, LAMB3, LAMB2, CAV1, FN1, VEGFC, BRAF, LAMB1, IGF1, COL1A1, DIAPH1, COL1A2, COL9A1, CTNNB1, COL9A3, COL9A2",1.4051698186703672e-19,KEGG_2019_Human
1.0,4,Lysosome,"HEXB, CLTC, HEXA, AP4E1, TCIRG1, LIPA, LITAF, SGSH, MFSD8, AP4M1, GNPTAB, NAGLU, CTSK, SMPD1, LAMP2, IDS, CTSF, GUSB, CTSD, CTSC, ARSA, HGSNAT, MANBA, ATP6AP1, GAA, AP3B1, NPC1, NPC2, IDUA, GBA, GNS, CLN5, CLN3, PSAP, NEU1, ATP6V0A2, SLC17A5, ATP6V0A4, AP4S1, AGA, ARSB, CTSA, FUCA1, CTNS, NAGA, MCOLN1, AP4B1, GALNS, GALC, GNPTG, GLB1, PPT1, TPP1, MAN2B1, GLA",6.645480276953207e-19,KEGG_2019_Human
1.0,5,PI3K-Akt signaling pathway,"CSF3R, IRS1, TNC, IGF1R, COMP, STK11, CCND2, FGF8, FGF9, PPP2R1A, AKT3, AKT1, PDGFRB, MAP2K1, G6PC, MAP2K2, TSC2, TSC1, COL4A2, COL4A1, COL4A4, COL4A3, COL4A5, RAF1, TP53, EPHA2, CSF1R, PDGFB, PIK3R2, PCK1, BDNF, INSR, IGF2, FN1, IGF1, NFKB1, COL1A1, COL1A2, CDK4, GNB1, COL9A1, COL9A3, COL9A2, FGFR3, FGFR2, FGFR1, CDKN1A, CDKN1B, LAMC3, FLT3, ITGB4, FLT4, PTEN, PIK3CD, LAMC2, BRCA1, GYS2, IKBKB, GHR, GYS1, RAC1, ITGB6, JAK2, HRAS, JAK3, YWHAG, JAK1, VWF, PPP2R5D, OSMR, COL2A1, PIK3CA, COL6A2, KIT, COL6A1, COL6A3, ITGA7, SOS1, SOS2, MET, TNXB, LAMA2, LAMA1, LAMA4, LAMA3, EGFR, INS, NRAS, RELN, ERBB3, ERBB4, ERBB2, MAPK1, NTRK1, NTRK2, LAMB3, LAMB2, VEGFC, LAMB1, MTOR, EPOR, KITLG, KRAS, TEK",7.608012073432611e-19,KEGG_2019_Human
1.0,6,Central carbon metabolism in cancer,"RET, FLT3, SLC2A1, PTEN, SLC2A2, PIK3CD, PIK3R2, PDHB, EGFR, HK1, NRAS, AKT3, ERBB2, AKT1, MAPK1, HRAS, PDGFRB, NTRK1, G6PD, MAP2K1, MAP2K2, PDHA1, IDH1, PGAM2, GCK, MTOR, PIK3CA, SCO2, KIT, KRAS, RAF1, TP53, MET, PFKM, FGFR3, FGFR2, FGFR1",3.2869897562954254e-17,KEGG_2019_Human
1.0,7,Hypertrophic cardiomyopathy (HCM),"RYR2, LAMA2, ITGB4, PRKAG2, ATP2A2, CACNA1D, CACNA1C, CACNA1F, ACTB, ACTG1, TTN, SGCD, SGCA, SGCB, LMNA, TNNI3, DMD, ITGB6, CACNA1S, EMD, SGCG, MYBPC3, TGFB2, ACE, TPM3, TGFB3, TPM2, CACNA2D1, TNNC1, TPM1, CACNA2D4, IGF1, CACNB2, DES, ACTC1, MYL2, TNNT2, MYL3, ITGA7, MYH6, MYH7",1.115325624412517e-15,KEGG_2019_Human
1.0,9,Hepatocellular carcinoma,"RB1, CDKN1A, SMARCB1, PTEN, PIK3CD, ACTB, ACTG1, IGF1R, AKT3, AKT1, POLK, ARID2, HRAS, PRKCG, MAP2K1, MAP2K2, SMARCC2, WNT5A, AXIN2, ARID1A, ARID1B, TGFBR1, TGFBR2, PIK3CA, RAF1, SOS1, TP53, SOS2, MET, TERC, LRP5, PIK3R2, EGFR, LRP6, NRAS, TERT, DVL1, PLCG2, DVL3, MAPK1, SMAD2, SMARCE1, WNT10B, TGFB2, WNT10A, SMAD4, SMAD3, FZD2, TGFB3, FZD4, CDKN2A, IGF2, BRAF, SMARCA2, MTOR, SMARCA4, APC, CDK4, CTNNB1, KRAS",2.913181728595745e-15,KEGG_2019_Human
1.0,8,Dilated cardiomyopathy (DCM),"RYR2, LAMA2, ITGB4, ATP2A2, CACNA1D, CACNA1C, CACNA1F, ACTB, ACTG1, ADCY5, TTN, SGCD, PLN, SGCA, SGCB, LMNA, TNNI3, DMD, ITGB6, CACNA1S, EMD, SGCG, MYBPC3, TGFB2, TPM3, TGFB3, TPM2, CACNA2D1, TNNC1, TPM1, CACNA2D4, IGF1, CACNB2, DES, ACTC1, MYL2, TNNT2, MYL3, GNAS, ITGA7, MYH6, MYH7",3.053436683390342e-15,KEGG_2019_Human
1.0,10,Cholesterol metabolism,"SCARB1, CETP, LRPAP1, PCSK9, LCAT, LPL, LRP2, ABCB11, LIPA, CYP7A1, LIPC, LIPG, CD36, APOE, LDLRAP1, APOB, LDLR, ABCA1, MYLIP, ABCG8, ABCG5, APOA1, APOC3, CYP27A1, NPC1, STAR, NPC2, APOC2, ANGPTL3, LPA",5.429814267352286e-15,KEGG_2019_Human
1.0,11,Proteoglycans in cancer,"CDKN1A, IHH, PIK3CD, ACTB, ACTG1, IGF1R, PPP1CB, SHH, AKT3, AKT1, PLCE1, TIMP3, RAC1, HRAS, PRKCG, MAP2K1, MAP2K2, WNT5A, ANK2, ANK3, ANK1, HSPG2, PIK3CA, RAF1, SOS1, TP53, SOS2, MET, CAMK2B, CAMK2A, ITPR1, TWIST1, PIK3R2, CBL, EGFR, CDC42, NRAS, ERBB3, ERBB4, ERBB2, PLCG2, GPC3, FLNA, MAPK1, FLNB, FLNC, SMAD2, WNT10B, WNT10A, TGFB2, FZD2, CAV3, FZD4, PTCH1, CAV1, STAT3, IGF2, FN1, BRAF, PTPN11, IGF1, MTOR, CTNNB1, FAS, KRAS, FGFR1",9.219793407061433e-15,KEGG_2019_Human
1.0,12,MAPK signaling pathway,"FLT3, FLT4, HSPB1, IGF1R, IKBKB, RPS6KA3, PPP3CA, FGF8, MECOM, FGF9, AKT3, AKT1, RAC1, HRAS, MAP3K7, PRKCG, PDGFRB, MEF2C, MAP2K1, MAP2K2, CACNA2D1, CACNA2D4, IRAK4, MAPK8IP3, DUSP6, TGFBR1, TNFRSF1A, TGFBR2, CACNB2, RASA1, KIT, MAPT, RAF1, SOS1, TP53, SOS2, MET, EPHA2, CSF1R, MAX, PDGFB, CACNA1B, CACNA1A, CACNA1D, CACNA1C, RASGRP2, CACNA1F, CACNA1E, EGFR, CACNA1H, CACNA1G, INS, CDC42, NRAS, ERBB3, ERBB4, ERBB2, FLNA, MAPK1, FLNB, FLNC, CACNA1S, NTRK1, NTRK2, TGFB2, MAP3K1, TGFB3, BDNF, INSR, IGF2, VEGFC, BRAF, IGF1, NFKB1, NFKB2, KITLG, NF1, FAS, TAB2, KRAS, TEK, FGFR3, FGFR2, FGFR1",1.2851214973102128e-14,KEGG_2019_Human
1.0,13,Chronic myeloid leukemia,"RB1, CDKN1A, CDKN1B, PIK3CD, PIK3R2, CBL, IKBKB, NRAS, MECOM, AKT3, ABL1, AKT1, MAPK1, POLK, HRAS, STAT5B, MAP2K1, TGFB2, SMAD4, MAP2K2, SMAD3, TGFB3, CDKN2A, PTPN11, BRAF, TGFBR1, NFKB1, RUNX1, TGFBR2, NFKBIA, PIK3CA, CDK4, KRAS, RAF1, SOS1, SOS2, TP53",1.462241231909346e-14,KEGG_2019_Human
1.0,14,AGE-RAGE signaling pathway in diabetic complications,"CDKN1B, PIK3CD, PIK3R2, CDC42, NRAS, AKT3, PLCG2, AKT1, PLCE1, MAPK1, RAC1, JAK2, HRAS, SMAD2, STAT5B, TGFB2, SMAD4, SMAD3, TGFB3, STAT1, STAT3, FN1, CYBB, VEGFC, NFKB1, TGFBR1, TGFBR2, COL1A1, DIAPH1, COL3A1, COL1A2, PLCB4, COL4A2, PIK3CA, COL4A1, CDK4, COL4A4, COL4A3, AGTR1, COL4A5, KRAS, PLCB1, PLCD1",1.863267618747055e-14,KEGG_2019_Human
1.0,15,Pancreatic cancer,"RB1, CDKN1A, PIK3CD, PIK3R2, BRCA2, EGFR, IKBKB, CDC42, AKT3, ERBB2, AKT1, MAPK1, POLK, RAC1, JAK1, SMAD2, MAP2K1, TGFB2, SMAD4, SMAD3, TGFB3, STAT1, CDKN2A, STAT3, BRAF, TGFBR1, NFKB1, MTOR, TGFBR2, RAD51, PIK3CA, CDK4, KRAS, RAF1, TP53, ARHGEF6",5.527543899777599e-14,KEGG_2019_Human
1.0,16,Breast cancer,"RB1, CDKN1A, FLT4, PTEN, PIK3CD, BRCA1, BRCA2, IGF1R, FGF8, FGF9, AKT3, AKT1, POLK, HRAS, MAP2K1, MAP2K2, WNT5A, AXIN2, PIK3CA, KIT, RAF1, SOS1, TP53, SOS2, NOTCH2, NOTCH3, NOTCH1, LRP5, PIK3R2, EGFR, LRP6, DLL3, DLL4, NRAS, DVL1, ERBB2, DVL3, MAPK1, WNT10B, WNT10A, FZD2, JAG1, FZD4, BRAF, IGF1, ESR2, MTOR, NFKB2, APC, CDK4, CTNNB1, KRAS, FGFR1",6.452683776630053e-14,KEGG_2019_Human
1.0,17,Gastric cancer,"RB1, CDKN1A, CDKN1B, PIK3CD, SHH, FGF8, FGF9, CDH1, AKT3, AKT1, POLK, HRAS, MAP2K1, MAP2K2, WNT5A, AXIN2, TGFBR1, TGFBR2, PIK3CA, RAF1, SOS1, TP53, SOS2, MET, TERC, LRP5, PIK3R2, EGFR, LRP6, NRAS, TERT, DVL1, ERBB2, CTNNA1, DVL3, MAPK1, SMAD2, WNT10B, TGFB2, WNT10A, SMAD4, SMAD3, FZD2, JUP, TGFB3, FZD4, BRAF, MLH1, MTOR, APC, CTNNB1, KRAS, FGFR2",1.1658189219634042e-13,KEGG_2019_Human
1.0,18,Thyroid hormone signaling pathway,"NOTCH2, NOTCH3, NOTCH1, HDAC3, THRA, SLC2A1, PIK3CD, ATP2A2, ATP1A3, GATA4, PIK3R2, ATP1A2, ACTB, ACTG1, MED17, MED12, NRAS, PLN, SIN3A, AKT3, PLCG2, AKT1, PLCE1, EP300, MAPK1, SLC16A2, HRAS, PRKCG, MAP2K1, CREBBP, MAP2K2, STAT1, TSC2, MTOR, MED13L, BMP4, PLCB4, PIK3CA, CTNNB1, KRAS, RAF1, PLCB1, TP53, MYH6, PLCD1",3.1313920904811287e-13,KEGG_2019_Human
1.0,19,Glioma,"RB1, CAMK2B, CDKN1A, CAMK2A, PTEN, PDGFB, PIK3CD, PIK3R2, EGFR, IGF1R, NRAS, AKT3, PLCG2, AKT1, MAPK1, POLK, HRAS, PDGFRB, PRKCG, MAP2K1, MAP2K2, CDKN2A, BRAF, IGF1, MTOR, PIK3CA, CDK4, CALM3, KRAS, RAF1, SOS1, CALM1, SOS2, TP53, CALM2",3.1363432000073886e-13,KEGG_2019_Human
1.0,20,Signaling pathways regulating pluripotency of stem cells,"BMPR2, PIK3CD, IGF1R, SOX2, ZIC3, AKT3, AKT1, JAK2, HRAS, JAK3, JAK1, ACVR1, MAP2K1, MAP2K2, WNT5A, PAX6, HNF1A, AXIN2, PIK3CA, KAT6A, RAF1, PIK3R2, NRAS, DVL1, HESX1, DVL3, MAPK1, SMAD2, WNT10B, WNT10A, SMAD4, ZFHX3, SMAD3, FZD2, FZD4, ESRRB, STAT3, SMAD9, IGF1, TBX3, BMP4, REST, APC, CTNNB1, KRAS, TCF3, FGFR3, FGFR2, FGFR1, BMPR1A",3.454689900024802e-13,KEGG_2019_Human
